ACER THERAPEUTICS INC. Diluted Shares Outstanding (Weighted Average)
ACER THERAPEUTICS INC. reported Diluted Shares Outstanding (Weighted Average) of 24.46 million shares for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2023-11-20
- ACER THERAPEUTICS INC. weighted average number of shares outstanding, diluted for the quarter ending 2023-09-30 was 24.46M shares, a 52.05% increase year-over-year.
- ACER THERAPEUTICS INC. weighted average number of shares outstanding, diluted for the quarter ending 2023-06-30 was 24.46M shares, a 38.35% increase year-over-year.
- ACER THERAPEUTICS INC. weighted average number of shares outstanding, diluted for the quarter ending 2023-03-31 was 21.11M shares, a 47.54% increase year-over-year.
- ACER THERAPEUTICS INC. weighted average number of shares outstanding, diluted for the quarter ending 2022-12-31 was 11.81M shares, a 17.47% decline year-over-year.
- ACER THERAPEUTICS INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 15.77M shares, a 10.51% increase from fiscal 2021.
- ACER THERAPEUTICS INC. weighted average number of shares outstanding, diluted for fiscal 2021 was 14.27M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | 24.46M shares 10-Q · filed 2023-11-20 | 24.46M shares derived: average of 2 quarters · filed 2023-11-20 | 23.25M shares 10-Q · filed 2023-11-20 | 20.46M shares derived: average of 4 quarters · filed 2023-11-20 | |
| 2023-06-30 | 24.46M shares 10-Q · filed 2023-08-14 | 22.77M shares 10-Q · filed 2023-08-14 | 19.13M shares derived: average of 3 quarters · filed 2023-08-14 | 18.37M shares derived: average of 4 quarters · filed 2023-11-20 | |
| 2023-03-31 | 21.11M shares 10-Q · filed 2023-05-15 | 16.46M shares derived: average of 2 quarters · filed 2023-05-15 | 16.34M shares derived: average of 3 quarters · filed 2023-11-20 | 16.67M shares derived: average of 4 quarters · filed 2023-11-20 | |
| 2022-12-31 | 11.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 13.95M shares derived: average of 2 quarters · filed 2023-11-20 | 15.19M shares derived: average of 3 quarters · filed 2023-11-20 | 15.77M shares 10-K · filed 2023-03-27 | |
| 2022-09-30 | 16.09M shares 10-Q · filed 2023-11-20 | 16.89M shares derived: average of 2 quarters · filed 2023-11-20 | 17.09M shares 10-Q · filed 2023-11-20 | 15.60M shares derived: average of 4 quarters · filed 2023-11-20 | |
| 2022-06-30 | 17.68M shares 10-Q · filed 2023-08-14 | 14.31M shares 10-Q · filed 2022-08-15 | 16.37M shares 10-Q · filed 2023-08-14 | 15.43M shares derived: average of 3 quarters · filed 2023-08-14 | 15.15M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | 14.31M shares 10-Q · filed 2023-05-15 | 14.31M shares derived: average of 2 quarters · filed 2023-05-15 | 14.31M shares derived: average of 3 quarters · filed 2023-05-15 | 14.31M shares derived: average of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | 14.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 14.31M shares derived: average of 2 quarters · filed 2023-03-27 | 14.31M shares derived: average of 3 quarters · filed 2023-03-27 | 14.27M shares 10-K · filed 2023-03-27 | |
| 2021-09-30 | 14.31M shares 10-Q · filed 2022-11-14 | 14.31M shares derived: average of 2 quarters · filed 2022-11-14 | 14.25M shares 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | 14.31M shares 10-Q/A · filed 2022-11-14 | 14.23M shares 10-Q/A · filed 2022-11-14 |